GME vs RXRX · P/E 16, rev $3.63B vs rev $14.1M
GameStop Corp. (GME) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
GME currently screens at market cap $9.78B and trailing P/E 16.3. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the GME and RXRX stock pages for the full models.
Not investment advice.